| Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant J Lopez Bernal, N Andrews, C Gower, E Gallagher, R Simmons, ... New England Journal of Medicine 385 (7), 585-594, 2021 | 3338 | 2021 |
| Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative … JL Bernal, N Andrews, C Gower, C Robertson, J Stowe, E Tessier, ... bmj 373, 2021 | 1347 | 2021 |
| Duration of protection against mild and severe disease by Covid-19 vaccines N Andrews, E Tessier, J Stowe, C Gower, F Kirsebom, R Simmons, ... New England Journal of Medicine 386 (4), 340-350, 2022 | 648 | 2022 |
| Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020 HI McDonald, E Tessier, JM White, M Woodruff, C Knowles, C Bates, ... Eurosurveillance 25 (19), 2000848, 2020 | 365 | 2020 |
| Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older … JL Bernal, N Andrews, C Gower, J Stowe, C Robertson, E Tessier, ... MedRxiv, 2021.03. 01.21252652, 2021 | 242 | 2021 |
| Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design J Stowe, E Tessier, H Zhao, R Guy, B Muller-Pebody, M Zambon, ... International journal of epidemiology 50 (4), 1124-1133, 2021 | 239 | 2021 |
| Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK N Andrews, E Tessier, J Stowe, C Gower, F Kirsebom, R Simmons, ... medrxiv, 2021.09. 15.21263583, 2021 | 189 | 2021 |
| Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B. 1.617. 2) variant J Stowe, N Andrews, C Gower, E Gallagher, L Utsi, R Simmons, ... Public health england, 2021 | 123 | 2021 |
| Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England G Amirthalingam, JL Bernal, NJ Andrews, H Whitaker, C Gower, J Stowe, ... Nature Communications 12 (1), 7217, 2021 | 110 | 2021 |
| Comparative transmission of SARS-CoV-2 Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) variants and the impact of vaccination: national cohort study, England H Allen, E Tessier, C Turner, C Anderson, P Blomquist, D Simons, ... Epidemiology & Infection 151, e58, 2023 | 89 | 2023 |
| Effectiveness of Covid-19 Vaccines against the B. 1.617. 2 (Delta) Variant. VR Emani, R Reddy, S Goswami The New England journal of medicine 385 (25), e92-e92, 2021 | 56 | 2021 |
| Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16 RG Pebody, MA Sinnathamby, F Warburton, N Andrews, NL Boddington, ... Eurosurveillance 23 (25), 1700496, 2018 | 52 | 2018 |
| Impact of the COVID-19 pandemic on Bordetella pertussis infections in England E Tessier, H Campbell, S Ribeiro, Y Rai, S Burton, P Roy, NK Fry, D Litt, ... BMC public health 22 (1), 405, 2022 | 48 | 2022 |
| Long-term health-related quality of life in non-hospitalized coronavirus disease 2019 (COVID-19) cases with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV … FG Sandmann, E Tessier, J Lacy, M Kall, E Van Leeuwen, A Charlett, ... Clinical Infectious Diseases 75 (1), e962-e973, 2022 | 45 | 2022 |
| Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England A Vusirikala, H Whitaker, S Jones, E Tessier, R Borrow, E Linley, ... Journal of Infection 83 (1), 104-111, 2021 | 36 | 2021 |
| Population-level factors predicting variation in influenza vaccine uptake among adults and young children in England, 2015/16 and 2016/17 E Tessier, F Warburton, C Tsang, S Rafeeq, N Boddington, ... Vaccine 36 (23), 3231-3238, 2018 | 30 | 2018 |
| Impact of extending the timing of maternal pertussis vaccination on hospitalized infant pertussis in England, 2014–2018 E Tessier, H Campbell, S Ribeiro, NK Fry, C Brown, J Stowe, N Andrews, ... Clinical Infectious Diseases 73 (9), e2502-e2508, 2021 | 27 | 2021 |
| Optimization of timing of maternal pertussis immunization from 6 years of postimplementation surveillance data in England G Amirthalingam, H Campbell, S Ribeiro, J Stowe, E Tessier, D Litt, ... Clinical Infectious Diseases 76 (3), e1129-e1139, 2023 | 25 | 2023 |
| Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data F McQuaid, R Mulholland, Y Sangpang Rai, U Agrawal, H Bedford, ... PLoS medicine 19 (2), e1003916, 2022 | 25 | 2022 |
| Effectiveness of BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on mortality following COVID-19 JL Bernal, N Andrews, C Gower, J Stowe, E Tessier, R Simmons, ... MedRxiv, 2021.05. 14.21257218, 2021 | 25 | 2021 |
